DS
LUMO

David Shaw’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

David Shaw’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,687
Closed -$306K – 3933
2018
Q1 		$306K Buy
+4,687
New +$332K ﹤0.01% 3142
2017
Q4 		– Sell
-2,492
Closed -$228K – 3782
2017
Q3 		$228K Sell
2,492
-2,175
-47% -$167K ﹤0.01% 3254
2017
Q2 		$309K Sell
4,667
-16,042
-77% -$1.99M ﹤0.01% 3020
2017
Q1 		$4.49M Buy
20,709
+8,120
+65% +$1.16M 0.01% 1362
2016
Q4 		$1.16M Buy
12,589
+9,363
+290% +$1.06M ﹤0.01% 2372
2016
Q3 		$436K Buy
3,226
+306
+10% +$30.4K ﹤0.01% 2865
2016
Q2 		$296K Sell
2,920
-591
-17% -$73.3K ﹤0.01% 3023
2016
Q1 		$575K Sell
3,511
-2
-0.1% -$405 ﹤0.01% 2708
2015
Q4 		$1.15M Sell
3,513
-1,467
-29% -$478K ﹤0.01% 2548
2015
Q3 		$1.61M Sell
4,980
-516
-9% -$227K ﹤0.01% 2254
2015
Q2 		$2.19M Buy
+5,496
New +$2.34M ﹤0.01% 2132
2015
Q1 		– Sell
-876
Closed -$313K – 4091
2014
Q4 		$313K Sell
876
-3,387
-79% -$1.01M ﹤0.01% 3627
2014
Q3 		$822K Sell
4,263
-1,217
-22% -$268K ﹤0.01% 2974
2014
Q2 		$1.31M Buy
5,480
+4,336
+379% +$882K ﹤0.01% 2690
2014
Q1 		$293K Sell
1,144
-5,443
-83% -$1.66M ﹤0.01% 3921
2013
Q4 		$1.3M Buy
+6,587
New +$1.17M ﹤0.01% 2929

Other funds holding LUMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

David Shaw's LUMO Position: Q2 2018 in Review

David Shaw sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 4,687 shares — an estimated $306K sold.

David Shaw first reported a position in LUMO in Q4 2013 and held it in 16 quarters. The position peaked at $4.49M in Q1 2017. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

  • David Shaw reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • David Shaw sold 4,687 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $306K.
  • David Shaw first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 16 quarters.
  • David Shaw's Lumos Pharma, Inc. Common Stock position peaked at $4.49M in Q1 2017.
  • 106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.